CRA published a report for Pharmaceutical Care Management Association on the potential effects on proposed changes to the definition of Medicare Part D prices. To read the report, click the link below.
France: A step towards more regulated drug prices
2022 was an expensive year for public spending in France, that led to a €18.9 billion debt for the social security system[1], of which almost 90% was driven by...